|
1
|
Siegel RLMK, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Center MM, Jemal A and Ward E:
International trends in colorectal cancer incidence rates. Cancer
Epidemiol Biomarkers Prev. 18:1688–1694. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Edwards BK, Ward E, Kohler BA, Eheman C,
Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I,
Seeff LC, et al: Annual report to the nation on the status of
cancer, 1975–2006, featuring colorectal cancer trends and impact of
interventions (risk factors, screening, and treatment) to reduce
future rates. Cancer. 116:544–573. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bosetti C, Levi F, Rosato V, Bertuccio P,
Lucchini F, Negri E and La Vecchia C: Recent trends in colorectal
cancer mortality in Europe. Int J Cancer. 129:180–191. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Favoriti P, Carbone G, Greco M, Pirozzi F,
Pirozzi RE and Corcione F: Worldwide burden of colorectal cancer: A
review. Updates Surg. 68:7–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aran V, Victorino AP, Thuler LC and
Ferreira CG: Colorectal cancer: Epidemiology, disease mechanisms
and interventions to reduce onset and mortality. Clin Colorectal
Cancer. 15:195–203. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guo J, Xu S, Huang X, Li L, Zhang C, Pan
Q, Ren Z, Zhou R, Ren Y, Zi J, et al: Drug resistance in colorectal
cancer cell lines is partially associated with aneuploidy status in
light of profiling gene expression. J Proteome Res. 15:4047–4059.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shi Y, Huang XX, Chen GB, Wang Y, Zhi Q,
Liu YS, Wu XL, Wang LF, Yang B, Xiao CX, et al: Dragon (RGMb)
induces oxaliplatin resistance in colon cancer cells. Oncotarget.
7:48027–48037. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dat NTBP, Binh PT, Quynh TP, Huong HT and
Minh CV: Sanggenon C and O inhibit NO production, iNOS expression
and NF-κB activation in LPS-induced RAW264.7 cells. Immunopharmacol
Immunotoxicol. 34:84–88. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sobral F, Calhelha RC, Barros L, Dueñas M,
Tomás A, Santos-Buelga C, Vilas-Boas M and Ferreira I: Flavonoid
composition and antitumor activity of bee bread collected in
northeast Portugal. Molecules. 22:pii: E248. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ren J, Zheng Y, Lin Z, Han X and Liao W:
Macroporous resin purification and characterization of flavonoids
from Platycladus orientalis (L.) Franco and their effects on
macrophage inflammatory response. Food Funct. 8:86–95. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jeong JJ and Kim DH:
5,7-Dihydroxy-6-methoxy-flavonoids eliminate HIV-1 D3-transfected
cytoprotective macrophages by inhibiting the PI3K/Akt signaling
pathway. Phytother Res. Jun 22–2015.(Epub ahead of print).
View Article : Google Scholar
|
|
14
|
Liu XY, Xu L, Wang Y, Li JX, Zhang Y,
Zhang C, Wang SS and Zhang XM: Protective effects of total
flavonoids of Astragalus against adjuvant-induced arthritis in rats
by regulating OPG/RANKL/NF-κB pathway. Int Immunopharmacol.
44:105–114. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang H, Liu N, Zhao K, Zhu C, Lu X, Li S,
Lian W, Zhou P, Dong X, Zhao C, et al: Sanggenon C decreases tumor
cell viability associated with proteasome inhibition. Front Biosci
(Elite Ed). 3:1315–1325. 2011.PubMed/NCBI
|
|
16
|
Li LCSF, Shen F, Hou Q and Cheng GF:
Inhibitory effect and mechanism of action of sanggenon C on human
polymorphonuclear leukocyte adhesion to human synovial cells. Acta
Pharmacol Sin. 23:138–142. 2002.PubMed/NCBI
|
|
17
|
Redza-Dutordoir M and Averill-Bates DA:
Activation of apoptosis signalling pathways by reactive oxygen
species. Biochim Biophys Acta. 1863:2977–2992. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nickel A, Kohlhaas M and Maack C:
Mitochondrial reactive oxygen species production and elimination. J
Mol Cell Cardiol. 73:26–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kaludercic N, Deshwal S and Di Lisa F:
Reactive oxygen species and redox compartmentalization. Front
Physiol. 5:2852014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zorov DB, Juhaszova M and Sollott SJ:
Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS
release. Physiol Rev. 94:909–950. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chong SJLI, Low IC and Pervaiz S:
Mitochondrial ROS and involvement of Bcl-2 as a mitochondrial ROS
regulator. Mitochondrion. 19:39–48. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pereira EJ, Smolko CM and Janes KA:
Computational models of reactive oxygen species as metabolic
byproducts and signal-transduction modulators. Front Pharmacol.
7:4572016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Murphy MP: Understanding and preventing
mitochondrial oxidative damage. Biochem Soc Trans. 44:1219–1226.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carraro M and Bernardi P: Calcium and
reactive oxygen species in regulation of the mitochondrial
permeability transition and of programmed cell death in yeast. Cell
Calcium. 60:102–107. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Görlach A, Bertram K, Hudecova S and
Krizanova O: Calcium and ROS: A mutual interplay. Redox Biol.
6:260–271. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou L, Zhang H and Wu J: Effects of
nitric oxide on the biological behavior of HepG2 human
hepatocellular carcinoma cells. Exp Ther Med. 11:1875–1880. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Astuti RI, Watanabe D and Takagi H: Nitric
oxide signaling and its role in oxidative stress response in
Schizosaccharomyces pombe. Nitric Oxide. 52:29–40. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang J, He P, Gaida M, Yang S, Schetter
AJ, Gaedcke J, Ghadimi BM, Ried T, Yfantis H, Lee D, et al:
Inducible nitric oxide synthase enhances disease aggressiveness in
pancreatic cancer. Oncotarget. 7:52993–53004. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vannini F, Kashfi K and Nath N: The dual
role of iNOS in cancer. Redox Biol. 6:334–343. 2015. View Article : Google Scholar : PubMed/NCBI
|
